v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Conversion of 2020 Notes to common stock
Conversion of 2021 Notes to common stock
Convertible Preferred Stock
Series 1-C Convertible Preferred Stock Warrants
Common Stock
Common Stock
Conversion of 2020 Notes to common stock
Common Stock
Conversion of 2021 Notes to common stock
Additional Paid-In Capital
Additional Paid-In Capital
Conversion of 2020 Notes to common stock
Additional Paid-In Capital
Conversion of 2021 Notes to common stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024       6,096,910                  
Beginning balance at Dec. 31, 2024       $ 99,652 $ 14,320                
Ending balance (in shares) at Mar. 31, 2025       6,096,910                  
Ending balance at Mar. 31, 2025       $ 99,652 14,320                
Beginning balance (in shares) at Dec. 31, 2024           10,145,962              
Beginning balance at Dec. 31, 2024 $ (493,091)         $ 1     $ 215,139     $ (22,364) $ (685,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) (55,964)                       (55,964)
Issuance of common stock for options exercised (in shares)           218,340              
Issuance of common stock for options exercised 1,912               1,912        
Stock-based compensation 3,493               3,493        
Other comprehensive income 2,109                     2,109  
Ending balance (in shares) at Mar. 31, 2025           10,364,302              
Ending balance at Mar. 31, 2025 (541,541)         $ 1     220,544     (20,255) (741,831)
Beginning balance (in shares) at Dec. 31, 2024       6,096,910                  
Beginning balance at Dec. 31, 2024       $ 99,652 14,320                
Ending balance (in shares) at Jun. 30, 2025       6,916,489                  
Ending balance at Jun. 30, 2025       $ 114,027 0                
Beginning balance (in shares) at Dec. 31, 2024           10,145,962              
Beginning balance at Dec. 31, 2024 (493,091)         $ 1     215,139     (22,364) (685,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) (35,459)                        
Other comprehensive income 17,623                        
Ending balance (in shares) at Jun. 30, 2025           10,465,908              
Ending balance at Jun. 30, 2025 (501,440)         $ 1     224,626     (4,741) (721,326)
Beginning balance (in shares) at Mar. 31, 2025       6,096,910                  
Beginning balance at Mar. 31, 2025       $ 99,652 14,320                
Convertible Preferred Stock                          
Issuance of preferred stock for warrant exercised (in shares)       819,579                  
Issuance of preferred stock for warrants exercised       $ 14,375 (14,320)                
Ending balance (in shares) at Jun. 30, 2025       6,916,489                  
Ending balance at Jun. 30, 2025       $ 114,027 $ 0                
Beginning balance (in shares) at Mar. 31, 2025           10,364,302              
Beginning balance at Mar. 31, 2025 (541,541)         $ 1     220,544     (20,255) (741,831)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) 20,505                       20,505
Issuance of common stock for options exercised (in shares)           101,606              
Issuance of common stock for options exercised 829               829        
Stock-based compensation 3,253               3,253        
Other comprehensive income 15,514                     15,514  
Ending balance (in shares) at Jun. 30, 2025           10,465,908              
Ending balance at Jun. 30, 2025 $ (501,440)         $ 1     224,626     (4,741) (721,326)
Beginning balance (in shares) at Dec. 31, 2025 6,916,489                        
Beginning balance at Dec. 31, 2025 $ 114,027                        
Ending balance (in shares) at Mar. 31, 2026 6,916,489                        
Ending balance at Mar. 31, 2026 $ 114,027                        
Beginning balance (in shares) at Dec. 31, 2025 10,847,267         10,847,267              
Beginning balance at Dec. 31, 2025 $ (521,380)         $ 1     233,705     (9,910) (745,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) (61,286)                       (61,286)
Issuance of common stock for options exercised (in shares)           210,729              
Issuance of common stock for options exercised 3,061               3,061        
Issuance of common stock for exercise or conversion (in shares)           31,008              
Issuance of common stock for exercise or conversion 208               208        
Issuance of common stock for settlement of RSUs, net of shares withheld for taxes (in shares)           11,362              
Issuance of common stock for settlement of RSUs, net of shares withheld for taxes (161)               (161)        
Settlement of promissory notes issued in exchange for the early exercise of stock options (in shares)           (410,593)              
Settlement of promissory notes issued in exchange for the early exercise of stock options (see Note 1) 9,072               9,072        
Stock-based compensation 2,784               2,784        
Other comprehensive income 1,989                     1,989  
Ending balance (in shares) at Mar. 31, 2026           10,689,773              
Ending balance at Mar. 31, 2026 $ (565,713)         $ 1     248,669     (7,921) (806,462)
Beginning balance (in shares) at Dec. 31, 2025 6,916,489                        
Beginning balance at Dec. 31, 2025 $ 114,027                        
Ending balance (in shares) at Jun. 30, 2026 6,916,489                        
Ending balance at Jun. 30, 2026 $ 114,027                        
Beginning balance (in shares) at Dec. 31, 2025 10,847,267         10,847,267              
Beginning balance at Dec. 31, 2025 $ (521,380)         $ 1     233,705     (9,910) (745,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) $ 234,093                        
Issuance of common stock for options exercised (in shares) 338,258                        
Other comprehensive income $ 20,435                        
Ending balance (in shares) at Jun. 30, 2026 50,819,969         50,819,969              
Ending balance at Jun. 30, 2026 $ 682,177         $ 5     1,182,730     10,525 (511,083)
Beginning balance (in shares) at Mar. 31, 2026 6,916,489                        
Beginning balance at Mar. 31, 2026 $ 114,027                        
Ending balance (in shares) at Jun. 30, 2026 6,916,489                        
Ending balance at Jun. 30, 2026 $ 114,027                        
Beginning balance (in shares) at Mar. 31, 2026           10,689,773              
Beginning balance at Mar. 31, 2026 (565,713)         $ 1     248,669     (7,921) (806,462)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) 295,379                       295,379
Issuance of common stock for options exercised (in shares)           127,529              
Issuance of common stock for options exercised 928               928        
Issuance of common stock for exercise or conversion (in shares)           27,131 12,648,586 27,326,950          
Issuance of common stock for exercise or conversion 183 $ 211,423 $ 683,174       $ 1 $ 3 183 $ 211,422 $ 683,171    
Stock-based compensation 38,357               38,357        
Other comprehensive income $ 18,446                     18,446  
Ending balance (in shares) at Jun. 30, 2026 50,819,969         50,819,969              
Ending balance at Jun. 30, 2026 $ 682,177         $ 5     $ 1,182,730     $ 10,525 $ (511,083)